PERRY ANDREW (Chief Commercial Officer) received a stock award from G1 THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/18/2024ACC: 0000950170-24-107787
Officer· Chief Commercial Officer
Since Aug 2021
-211.76K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
5
Total transactions
16.10K acquired · 227.86K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+16.10K
Price / share
—
Trade value
—
% of position
14.3%
9/18/2024
112.61K→128.71K
Common Stock
Direct
Shares
−114.48K
Price / share
—
Trade value
—
% of position
88.9%
9/18/2024
128.71K→14.23K
Common Stock
Direct
Shares
−14.23K
Price / share
—
Trade value
—
% of position
New position
9/18/2024
14.23K→0.00
Total
Net shares
−112.61K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/18/2024 | A · Award | +16.10K | — | — | 14.3% | 112.61K | 128.71K |
| Common Stock Direct | 9/18/2024 | D · Disposition | −114.48K | — | — | 88.9% | 128.71K | 14.23K |
| Common Stock Direct | 9/18/2024 | U · U | −14.23K | — | — | New position | 14.23K | 0.00 |
| Total | −112.61K | $0.00 | ||||||
Derivative Transactions2
Stock Option (right to buy)
Direct
Converts to
Common Stock
67.05K shares
Shares
−67.05K
Strike price
2.97
Held after
0.00
Exercisable
—
9/18/2024
Stock Option (right to buy)
Direct
Converts to
Common Stock
32.10K shares
Shares
−32.10K
Strike price
5.73
Held after
0.00
Exercisable
—
9/18/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock67.05K shares | 9/18/2024 | D · Disposition | −67.05K | 2.97 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock32.10K shares | 9/18/2024 | D · Disposition | −32.10K | 5.73 | — | 0.00 |